Technology Transfer has always been a hot topic and can be even more challenging for complex processes/products like biotechnological ones.
In this Covid-19 pandemic era, different companies are facing technology transfer processes as a mandatory way to boost their covid vaccines production and follow patients’ need, shifting a series of contract manufacturers across the world that must inherit their technology and achieve compliance in a really short timing to meet the production goals.
Transferring a process means taking what was developed in one original company and replicate it into another one: it seems easy but only on the paper! Equipment, utilities, methodologies and documentation can be very different between different companies and this can represent a real challenge once a process needs to be transferred. Moreover, once the transfer is completed successfully it has to be validated, time constraints are also present, even more in the current challenging situation.